The resulting FSHD patient-derived myocytes, but not the control-derived ones, expressed DUX4 as well as several of its target genes, and were used to model the effects of oxidative stress on DUX4 expression. The gene discussed is DUX4; the disease is facioscapulohumeral muscular dystrophy.